Lumen Research rates the iShares MSCI Global Silver and Metals Miners ETF (SLVP) as Buy, citing strong earnings leverage to rising silver prices and robust margins in Q2. In contrast, the Kurv Silver Enhanced Income ETF (KSLV) is rated Hold because its high yield mainly returns capital and has underperformed SLVP in total returns, partly due to option strategies limiting gains. With silver expected to remain in deficit and interest rates posing risks, SLVP's potential for price appreciation is favored over KSLV's income approach for the next 6 to 12 months. This analysis highlights the trade-off between growth potential and income in silver-related ETFs amid market volatility.
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
Red Cat Holdings announced a voluntary public purchase offer to acquire all outstanding shares of Steyr Motors AG at €39 per share in cash, representing a significant premium over recent prices. The acquisition aims to strengthen Red Cat's Blue Ops u...
The VanEck Semiconductor ETF (SMH) dropped nearly 10% due to a rotation of capital from AI and tech stocks into sectors like Financials and Energy amid worsening liquidity and macroeconomic challenges. The portfolio manager reduced cash holdings from...
Telix Pharmaceuticals and Ekalia have teamed up to establish U.S.-based production of astatine-211, a rare alpha-emitting isotope used in targeted alpha therapy for cancer. This collaboration combines IBA's cyclotron technology, Framatome's nuclear e...
Ekalia, a joint venture between IBA and Framatome, has partnered with Telix Pharmaceuticals to accelerate the production of Astatine-211, a promising alpha-emitting radioisotope used in targeted cancer therapies, in the United States. The collaborati...
